title: [Brain metastases of lung cancer].
abstract: Cerebral metastases are a frequent complication of lung cancer. They often determine patients' prognosis and need urgent therapeutic intervention. Based on histologic type, former therapies, age and performance of the patient, the number of cerebral lesions and the extracerebral tumour activity, individualized treatments are applied. For patients who suffer from non-small cell lung cancer and a single CNS lesion the best results can be achieved if they are surgically resected or receive radiosurgery. Their survival time can be markedly increased in comparison to patients who undergo whole brain irradiation. If multiple metastases are seen in CT or MRI, whole brain irradiation is the therapy to choose. Furthermore it should be initiated if small cell lung cancer metastasizes to the brain. More aggressive local treatment options appear promising, but a clear role for them has not yet been defined. Systemic chemotherapy gains more attention in the treatment of small and non-small cell lung cancer with brain metastases. How to increase the efficacy through simultaneous application of chemo- and radiotherapy is tested in current trials. This article gives an overview on clinical presentation and diagnosis of cerebral metastases in lung cancer and reviews current treatment options.
authors.affiliation: Medizinische Klinik m. S. Infektiologie und Pneumologie, Charité -- Universitätsmedizin Berlin. daniel.binder@charite.de
authors.forename: D
authors.initials: D
authors.lastname: Binder
authors.forename: B
authors.initials: B
authors.lastname: Temmesfeld-Wollbrück
authors.forename: R
authors.initials: R
authors.lastname: Wurm
authors.forename: C
authors.initials: C
authors.lastname: Woiciechowsky
authors.forename: C
authors.initials: C
authors.lastname: Schäper
authors.forename: D
authors.initials: D
authors.lastname: Schürmann
authors.forename: N
authors.initials: N
authors.lastname: Suttorp
authors.forename: T
authors.initials: T
authors.lastname: Beinert
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D004487:Edema / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000473:pathology*; D009362:Neoplasm Metastasis; D010166:Palliative Care; D011379:Prognosis
chemical_list: D000927:Anticonvulsants